Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)

China · Delayed Price · Currency is CNY

3.940

-0.040 (-1.01%)

Sep 2, 2026, 3:04 PM CST

SHE:000518 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	273.23	344.38	203.52	235.42	270.15	350.96
Revenue Growth	-2.28%	69.22%	-13.55%	-12.86%	-23.03%	-30.56%
Gross Profit	83.25	122.23	90.11	147.34	183.79	235.85
Operating Income	-61.59	-44.2	-68.29	-67.21	-49.56	-35.16
Net Income	-52.83	-37.09	-109.99	-75.27	-48.79	-34.79
Earnings Per Share	-0.05	-0.04	-0.11	-0.07	-0.05	-0.03
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Medicine	184.76	198.1
Others	1.01	1.33
Forest	158.62	4.09
Total	344.38	203.52

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	71.08	89.69	8.18	19.06	28.34	38.34
Total Debt	35.61	30.16	36.27	47.9	48.75	51.1
Net Cash (Debt)	35.47	59.54	-28.09	-28.84	-20.41	-12.77
Net Cash Growth	64.53%	-	-	-	-	-
Net Cash Per Share	0.03	0.06	-0.03	-0.03	-0.02	-0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	10.69	78.12	1.46	1.63	4.87	0.16
Capital Expenditures	-4.65	-3.6	-5.56	-8.19	-8.47	-7.69
Free Cash Flow	6.04	74.52	-4.1	-6.56	-3.61	-7.53
Free Cash Flow Growth	-86.86%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	30.47%	35.49%	44.27%	62.59%	68.03%	67.20%
Operating Margin	-22.54%	-12.83%	-33.56%	-28.55%	-18.34%	-10.02%
Pretax Margin	-21.31%	-11.88%	-55.88%	-33.74%	-19.84%	-10.27%
Profit Margin	-19.33%	-10.77%	-54.05%	-31.97%	-18.06%	-9.91%
FCF Margin	2.21%	21.64%	-2.01%	-2.79%	-1.34%	-2.15%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
P/FCF Ratio	678.74	33.30	-	-	-	-
PS Ratio	15.00	7.21	12.80	14.52	12.08	10.65